George Lundberg, MD Editor in Chief at Cancer Commons
-
August 15, 2020
Intraoperative MRI Versus 5-ALA in High-Grade Glioma Resection: A Network Meta-Analysis Bookmark
George Lundberg, MDResearch paper from the Journal of Neurosurgery curated by Editor in Chief George Lundberg, MD, who notes:
The extent of tumor resection—how much of the tumor is able to be removed—at the initial surgery is probably the most important factor in prognosis of glioblastoma. This academic research paper explores methods that help surgeons maximize tumor removal.
Go to full paper published in the Journal of Neurosurgery.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 15, 2020
Lung cancer at ASCO20 Virtual Bookmark
George Lundberg, MDResearch highlight from Nature Reviews Clinical Oncology curated by Editor in Chief George Lundberg, MD, who notes:
This year’s virtual meeting of the American Society of Clinical Oncology featured presentations on several different targeted therapies that appear to provide improved outcomes for lung cancer patients.
Go to full research highlight published by Nature Reviews Clinical Oncology.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 15, 2020
ICI for Resected Stage IV Melanoma Bookmark
George Lundberg, MDResearch highlight from Nature Reviews Clinical Oncology curated by Editor in Chief George Lundberg, MD, who notes:
In a clinical trial for metastatic melanoma patients, a combination of the drugs nivolumab and ipilimumab (both “immune checkpoint inhibitors,” or ICIs) outperformed nivolumab on its own, and nivolumab on its own outperformed a placebo.
Go to full research highlight published by Nature Reviews Clinical Oncology.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 15, 2020
New Focus on ADT in Prostate Cancer Guideline Bookmark
George Lundberg, MDArticle from MedPage Today curated by Editor in Chief George Lundberg, MD, who notes:
Hormone therapy has been a mainstay in the treatment of metastatic prostate cancer. But, until now, guidelines have been short on detail. This news story outlines 38 approved additions to guidelines.
Go to full article published by MedPage Today.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 15, 2020
A Case of Male Breast Cancer Patient with CHEK2*1100delC Mutation Bookmark
George Lundberg, MDResearch paper from Cureus curated by Editor in Chief George Lundberg, MD, who notes:
Breast cancer in men is unusual but important. This academic paper outlines the case of a specific patient who was found to have a genetic mutation that could explain why he was diagnosed at a relatively younger age.
Go to full paper published in Cureus.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 15, 2020
Key Studies in Metastatic Breast Cancer From ASCO 2020 Bookmark
George Lundberg, MDArticle from Medscape curated by Editor in Chief George Lundberg, MD, who notes:
This year’s virtual meeting of the American Society of Clinical Oncology (ASCO) featured five important studies on metastatic breast cancer, as outlined in this video.
Go to full article and video published by Medscape.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 14, 2020
Is Polio the Answer to Curing Brain Tumors? Bookmark
George Lundberg, MDArticle from WKYC Studios curated by Editor in Chief George Lundberg, MD, who notes:
An experimental treatment in which the virus that causes polio is directly injected into glioblastoma (GBM) tissue has shown some promise, as reported in the New England Journal of Medicine in 2018. This news story from WKYC provides a partial update from an ongoing subsequent clinical trial.
Go to full article published by WKYC Studios.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 14, 2020
A Phase II Randomized, Multicenter, Open-Label Trial of Continuing Adjuvant Temozolomide Beyond Six Cycles in Patients With Glioblastoma (GEINO 14-01) Bookmark
George Lundberg, MDResearch paper from Neuro-Oncology curated by Editor in Chief George Lundberg, MD, who notes:
These clinical trial results suggest that six cycles of temozolomide is as effective as 12 for patients with glioblastoma and produces fewer side effects.
Go to full paper published in Neuro-Oncology.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 14, 2020
Global Post-Marketing Safety Surveillance of Tumor Treating Fields (TTFields) in Patients With High-Grade Glioma in Clinical Practice Bookmark
George Lundberg, MDResearch paper from the Journal of Neuro-Oncology curated by Editor in Chief George Lundberg, MD, who notes:
Safety and potential adverse effects are serious issues with many cancer treatments. This academic paper outlines post-marketing research that reveals few adverse effects from a type of treatment known as tumor-treating fields (TTF) in brain malignancies.
Go to full paper published in the Journal of Neuro-Oncology.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 14, 2020
Exploiting Cancer’s Tactics to Make Cancer a Manageable Chronic Disease Bookmark
George Lundberg, MDResearch paper from Cancers curated by Editor in Chief George Lundberg, MD, who notes:
Instead of focusing on “curing” cancer, the authors of this academic research paper focus on approaches to managing cancer as a chronic disease.
Go to full paper published in Cancers.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.